MAPT and Alzheimer disease: Besides the accumulation of soluble and insoluble Aβ, the intraneuronal abundance of hyperphosphorylated filamentous tau protein represents the second major pathological signature of AD [32]–[34], which correlates well with cognitive impairment [35], [36].